Literature DB >> 11949984

Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults.

Peter Fried1, Barbara Watkinson, Deborah James, Robert Gray.   

Abstract

BACKGROUND: Assessing marijuana's impact on intelligence quotient (IQ) has been hampered by a lack of evaluation of subjects before they begin to use this substance. Using data from a group of young people whom we have been following since birth, we examined IQ scores before, during and after cessation of regular marijuana use to determine any impact of the drug on this measure of cognitive function.
METHODS: We determined marijuana use for seventy 17- to 20-year-olds through self-reporting and urinalysis. IQ difference scores were calculated by subtracting each person's IQ score at 9-12 years (before initiation of drug use) from his or her score at 17-20 years. We then compared the difference in IQ scores of current heavy users (at least 5 joints per week), current light users (less than 5 joints per week), former users (who had not smoked regularly for at least 3 months) and non-users (who never smoked more than once per week and no smoking in the past two weeks).
RESULTS: Current marijuana use was significantly correlated (p < 0.05) in a dose-related fashion with a decline in IQ over the ages studied. The comparison of the IQ difference scores showed an average decrease of 4.1 points in current heavy users (p < 0.05) compared to gains in IQ points for light current users (5.8), former users (3.5) and non-users (2.6).
INTERPRETATION: Current marijuana use had a negative effect on global IQ score only in subjects who smoked 5 or more joints per week. A negative effect was not observed among subjects who had previously been heavy users but were no longer using the substance. We conclude that marijuana does not have a long-term negative impact on global intelligence. Whether the absence of a residual marijuana effect would also be evident in more specific cognitive domains such as memory and attention remains to be ascertained.

Entities:  

Mesh:

Year:  2002        PMID: 11949984      PMCID: PMC100921     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  19 in total

1.  Self-reported medical use of marijuana: a survey of the general population.

Authors:  A C Ogborne; R G Smart; E M Adlaf
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Marijuana: federal smoke clears, a little.

Authors: 
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

Review 3.  A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function.

Authors:  P A Fried; A M Smith
Journal:  Neurotoxicol Teratol       Date:  2001 Jan-Feb       Impact factor: 3.763

4.  Cannabis and cognitive functions: a prospective study.

Authors:  V K Varma; A K Malhotra; R Dang; K Das; R Nehra
Journal:  Drug Alcohol Depend       Date:  1988-05       Impact factor: 4.492

5.  Toxic effects of chronic marihuana use.

Authors:  H Kolansky; W T Moore
Journal:  JAMA       Date:  1972-10-02       Impact factor: 56.272

6.  Excretion patterns of cannabinoid metabolites after last use in a group of chronic users.

Authors:  G M Ellis; M A Mann; B A Judson; N T Schramm; A Tashchian
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

7.  The residual cognitive effects of heavy marijuana use in college students.

Authors:  H G Pope; D Yurgelun-Todd
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

8.  Apparent half-life of excretion of cannabinoids in man.

Authors:  J S Cridland; D Rottanburg; A H Robins
Journal:  Hum Toxicol       Date:  1983-10

9.  Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.

Authors:  E Johansson; S Agurell; L E Hollister; M M Halldin
Journal:  J Pharm Pharmacol       Date:  1988-05       Impact factor: 3.765

Review 10.  Prospective, longitudinal assessment of developmental neurotoxicity.

Authors:  J L Jacobson; S W Jacobson
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

View more
  43 in total

1.  Effects of marijuana on young adults.

Authors:  Ian Shrier
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Effects of marijuana on young adults.

Authors:  Maggie Mamen
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

3.  Effects of marijuana on young adults.

Authors:  Paul J Yong
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

Review 4.  Emerging roles for endocannabinoids in long-term synaptic plasticity.

Authors:  Gregory L Gerdeman; David M Lovinger
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

5.  Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Authors:  Anthony Klugman; John Gruzelier
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

6.  Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder.

Authors:  Michael D De Bellis; Lihong Wang; Sara R Bergman; Richard H Yaxley; Stephen R Hooper; Scott A Huettel
Journal:  Drug Alcohol Depend       Date:  2013-06-14       Impact factor: 4.492

7.  Long-term effects of adolescent-onset and persistent use of cannabis.

Authors:  Raul Gonzalez; James M Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

8.  Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Authors:  April D Thames; Natalie Arbid; Philip Sayegh
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

9.  Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men.

Authors:  Chukwuemeka N Okafor; Michael W Plankey; Michael Li; Xinguang Chen; Pamela J Surkan; Steve Shoptaw; Eileen Martin; Ronald Cohen; Ned Sacktor; Robert L Cook
Journal:  Subst Use Misuse       Date:  2019-01-30       Impact factor: 2.164

10.  The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Grant Christopher Luckey; Gianluca Boi; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.